The role of informed consent in aneuploidy screening

Ultrasound in Obstetrics and Gynecology

Volumn 28, Issue 3, 2006, Pages 241-

  Treadwell, M C ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANEUPLOIDY; ANXIETY; COGNITIVE DEFECT; DECISION MAKING; EDUCATION; HUMAN; INFORMED CONSENT; MATERNAL SERUM; NOTE; NUCHAL TRANSLUCENCY MEASUREMENT; PATIENT AUTONOMY; PREGNANCY; PRENATAL SCREENING; PRIORITY JOURNAL; RISK ASSESSMENT; SCREENING TEST; TRISOMY 21;

ADULT; ANEUPLOIDY; FEMALE; GENETIC SCREENING; HUMANS; INFORMED CONSENT; PREGNANCY;

EID: 33748786215     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.3806     Document Type: Note

References (5)

1. DeVigan C, Vodovar V, Goujard J, Garel M, Vayssiere C, Goffinet F. Mothers' knowledge of screening for trisomy 21 in 1999: a survey in Paris maternity units. Eur J Obstet Gynecol Reprod Biol 2002; 104: 14-20.
2. Khoshnood B, DeVigan C, Blondel B, Lhomme A, Vodovar V, Garel M, Goffinet F. Women's interpretation of an abnormal result on measurement of fetal nuchal translucency and maternal serum screening for prenatal testing of Down syndrome. Ultrasound Obstet Gynecol 2006; 28: 242-248.
3. Khoshnood B, Blondel B, DeVigan C, Breart G. Socioeconomic barriers to informed decision making regarding maternal serum screening for Down syndrome: results of the French national perinatal survey of 1998. Am J Public Health 2004; 94: 484-491.
4. Nicolaides KH, Chervenak FA, McCullough LB, Avgidou K, Papageorghiou A. Evidence-based ethics and informed decision-making by pregnant women about invasive diagnosis after first-trimester assessment of risk for trisomy 21. Am J Obstet Gynecol 2005; 193: 322-326.
5. Muller MA, Bleker OP, Bonsel GJ, Bilardo CM. Nuchal translucency screening and anxiety levels in pregnancy and puerperium. Ultrasound Obstet Gynecol 2006; 27: 357-361.